VMP 34819511000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Magnesium trisilicate compound tablets
BNF code 0101010J0AAAHAH
Virtual Therapeutic Moiety Aluminium hydroxide + Magnesium trisilicate
Date identifier became valid 5 Oct 2017
Previous product identifier 316943005
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Magnesium trisilicate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Aluminium hydroxide dried
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 120.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Magnesium trisilicate compound tablets (A A H Pharmaceuticals Ltd)
Magnesium trisilicate compound tablets (Kent Pharma (UK) Ltd)
Virtual Medicinal Product Packs
Magnesium trisilicate compound tablets 100 tablet
Magnesium trisilicate compound tablets 500 tablet

dm+d data retrieved from TRUD: release NHSBSA_6.1.0_20240610000001, imported on 10th June 2024 at 04:56:37.

Feedback